Prenatal marijuana exposure confirmed by meconium testing linked to lower birth weight
Among 1,540 newborns with meconium drug testing, those positive for THC had significantly lower birth weight (0.16 kg less) and nearly twice the odds of low birth weight compared to unexposed infants.
Quick Facts
What This Study Found
Neonates exposed to THC had significantly lower birth weight, head circumference, and length (all p<0.001). THC-exposed neonates had 1.9 times the odds of low birth weight (95% CI 1.3-2.7). Birth weight was on average 0.16 kg lower in THC-exposed infants after controlling for confounders.
Key Numbers
1,540 meconium screens analyzed. 483 positive for THC only. Birth weight 0.16 kg lower (95% CI 0.10-0.22, p<0.001). OR for low birth weight: 1.9 (95% CI 1.3-2.7). Significantly lower head circumference and length as well.
How They Did This
Retrospective cohort using meconium drug screens from infants born in a Pacific Northwest hospital system over 2.5 years. 1,540 screens analyzed: 483 positive for THC only (no other drugs) compared to negative screens. Multivariable regression controlled for confounders.
Why This Research Matters
This study overcomes a major limitation of prior research by using meconium drug testing instead of maternal self-report, providing more reliable exposure data. The consistent findings across multiple growth measures strengthen the evidence.
The Bigger Picture
By isolating THC-only exposure (excluding polysubstance use) and using objective meconium testing, this study provides some of the cleanest evidence linking prenatal cannabis exposure to reduced fetal growth.
What This Study Doesn't Tell Us
Retrospective design. Meconium testing confirms exposure but does not measure dose, timing, or frequency. Hospital system population may not generalize. Unknown confounders despite multivariable adjustment. Single geographic region.
Questions This Raises
- ?Is there a dose-response relationship between prenatal THC exposure and birth weight reduction?
- ?Do these growth differences persist into childhood?
Trust & Context
- Key Stat:
- 1.9x odds of low birth weight with prenatal THC exposure
- Evidence Grade:
- Large retrospective cohort using objective exposure measurement (meconium testing) with multivariable adjustment.
- Study Age:
- Published in 2022.
- Original Title:
- Prenatal marijuana exposure and neonatal outcomes: a retrospective cohort study.
- Published In:
- BMJ open, 12(9), e061167 (2022)
- Authors:
- Jones, Michael James, Lotfi, Asma, Lin, Amber(2), Gievers, Ladawna L, Hendrickson, Robert, Sheridan, David C
- Database ID:
- RTHC-03940
Evidence Hierarchy
Looks back at existing records to find patterns.
What do these levels mean? →Frequently Asked Questions
Does using marijuana during pregnancy affect birth weight?
In this study of 1,540 newborns, those with THC confirmed in meconium testing had birth weights averaging 0.16 kg lower and nearly twice the odds of being classified as low birth weight.
How was marijuana exposure confirmed in this study?
Instead of relying on mothers' self-report, this study used meconium (first stool) drug testing to objectively confirm THC exposure, providing more reliable exposure data than most prior studies.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-03940APA
Jones, Michael James; Lotfi, Asma; Lin, Amber; Gievers, Ladawna L; Hendrickson, Robert; Sheridan, David C. (2022). Prenatal marijuana exposure and neonatal outcomes: a retrospective cohort study.. BMJ open, 12(9), e061167. https://doi.org/10.1136/bmjopen-2022-061167
MLA
Jones, Michael James, et al. "Prenatal marijuana exposure and neonatal outcomes: a retrospective cohort study.." BMJ open, 2022. https://doi.org/10.1136/bmjopen-2022-061167
RethinkTHC
RethinkTHC Research Database. "Prenatal marijuana exposure and neonatal outcomes: a retrosp..." RTHC-03940. Retrieved from https://rethinkthc.com/research/jones-2022-prenatal-marijuana-exposure-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.